DOMINIQUE BLAGOJEVIC: Open Payments
NPI 1821725888 · NEW FRANKLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 12 payments from 8 companies in 2025. Trend: 2023 $268 · 2024 $282 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: JARDIANCE, VRAYLAR, QULIPTA, UBRELVY, INSPIRE, Wegovy, Veozah, MOUNJARO.
Industry payments across OH — which companies pay providers there.
